Wireless heart failure sensor technology gets $37.9m
This article was originally published in Clinica
Wireless sensing specialist CardioMEMS has raised $37.9m in additional financing from its existing shareholders. The funds will enable the company to complete the US pivotal trial of its wireless heart failure pressure measurement system. The Atlanta, Georgia firm said it completed enrolment of its 550-patient CHAMPION clinical trial in 2009, and expects to have the results in the second half of this year. CardioMEMS' wireless heart failure sensor is a miniature device that is implanted into the patient’s pulmonary artery using a catheter-based procedure. Following the procedure, patients can take measurements of their pulmonary artery pressure wirelessly from home, using a proprietary electronic monitoring system. The data is immediately transmitted to a database and is available for review by the doctor on the CardioMEMS website.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.